https://www.relaytx.com | United States | 2016 | $520M
Relay Therapeutics is a clinical-stage precision medicine company based in the United States that combines computational skills with experimental approaches across structural biology, biophysics, chemistry, and biology to design therapies against validated but previously intractable targets. The company’s “Dynamo"platform integrates experimental and computational techniques to enable the visualization of protein motion and understand how protein conformation regulates function. This allows Relay Therapeutics to more effectively drug targets that have previously been difficult to address, particularly in the areas of precision oncology and genetic diseases. The company has assembled a “world-class team"and is advancing a pipeline of promising therapeutic candidates, with one clinical trial ongoing.
